References
- Symons HJ, Chen AR, Luznik L, . Myeloablative haploidentical bone marrow transplantation with T cell replete grafts and post-transplant cyclophosphamide: results of a phase II clinical trial. Blood 2011;118:(Suppl. 1): Abstract 4151.
- Pileri SA, Grogan TM, Harris NL, . Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002;41:1–29.
- Patel S, Said J, Song S, . A case of hemolytic anemia and severe thrombocytopenia related to histiocytic sarcoma. Leuk Res 2010;34:e257–s258.
- Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004;28:1133–1144.
- Vos JA, Abbondanzo SL, Barekman CL, . Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 2005;18:693–704.
- Gergis U, Dax H, Ritchie E, . Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature. J Clin Oncol 2011;29:e251–e253.
- Abidi MH, Tove I, Ibrahim RB, . Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. Am J Hematol 2007;82:932–933.
- Cazin B, Gorin NC, Jouet JP, . Successful autologous bone marrow transplantation in second remission of malignant histiocytosis. Bone Marrow Transplant 1990;5:431–433.
- Vowels MR, White L, Lam-Po-Tang PR. Bone marrow transplantation for malignant histiocytosis. Bone Marrow Transplant 1987;2:110.
- Berry J, Russell JA. Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant. Bone Marrow Transplant 1989;4:123–124.
- Mainardi C, D’Amore ES, Pillon M, . A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant. Leuk Lymphoma 2011;52:1367–1371.
- Zhai M, Hu L, Chen H. Allogeneic bone marrow transplantation for a patient with malignant histiocytosis. Zhonghua Xue Ye Xue Za Zhi 1997;18:395–396.
- Luznik L, Jones RJ, Fuchs EJ. High-dose cyclophosphamide for graft-versus-host disease prevention. Curr Opin Hematol 2010;17: 493–499.
- Brunstein CG, Fuchs EJ, Carter SL, . Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011;118:282–288.
- Bolanos-Meade J, Luznik L, Muth M, . Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. Bone Marrow Transplant 2009;43:477–480.